Critical limits of laboratory results need urgent notification to the clinician because they are an indicator of a critical or even life-threatening condition of the patient.
The publications about this topic are mainly from the 1970s. Since then, many laboratory methods have been improved, new parameters have been added, and there have also been changes in the evaluation and treatment of diseases.
Against this background and at the request of the American Medical Association, J.G. Kost [1] conducted a survey on critical pa-rameters in the USA in 1990 and Howanitz et al. [2] in 2002. The spectrum of critical pa-rameters reported in these publications does not meet the requirements of laboratory medicine in every respect.
I have therefore put together a new list of qualitative and quantitative parameters. If you think there are parameters that should perhaps be added or deleted, limits, which need changing, or notes that need to be amended, your suggestions would be most welcome.
Quantitative laboratory test results for the blood and extravascular body fluids are indicators, for example, of organic disease, metabolic disorders, diseases of the haematopoietic system, disturbances of haemostasis, abnormalities of the endocrine system, activation or insufficiency of the immune system, inflammation, infections, and autoimmune processes.
High detection sensitivity, a wide measurement range, and good to acceptable precision and accuracy, allow blood parameters to be determined in concentration ranges, which indicate that the patient is in acute danger or even a danger to others. The laboratory must report such results to the treating physi-cian immediately. For this to happen, there must be an agreement between the treating physician and the laboratory as to what constitutes a critical result that needs to be reported to him. The parameters chosen and the critical limits depend essentially on the disease prevalence expected in the clinic or practice.
The laboratory should not report a criti-cal result to the treating physician until it has been confirmed by a second deter-mination in the same sample.
The laboratory test value should be ascertained by a competent member of the laboratory (laboratory doctor, clinical chemist, senior medical laboratory tech-nician) who should discuss the result with the treating physician. This is because influences and interfer-ence factors in the preanalytical phase, e.g. sample collection for glucose measurement using a venous catheter that had been used for glucose infusion, are not infrequently the cause of seemingly critical values. Such cases are usually clarified by the testing of another, properly collected sample.
The specified parameters and limits are taken partly from [1] . The others are based on 25 years' experience as a doctor for laboratory medicine working in a hospital. Decrease in the vitamin K-dependent factors II, VII, and X or in factor V. Since all these factors are synthesized in the liver, a decrease in the TT to values below the specified level indicates a considerable disturbance of synthesis. In persons receiving coumarin therapy, there is a risk of haemorrhage if the TT is < 15% -which corresponds roughly to an INR of > 4.
Platelet count < 20,000/ml > 1 million/ml Risk of haemorrhage. Exclude EDTA-induced thrombocytopenia.
Risk of thrombosis. Indicative of acute renal failure; unlike pre-renal and post-renal kidney failure, no disproportionate increase in urea compared to creatinine in serum. Urgent clarification of pathogenicity required.
Indicative of marked anemia with an inadequate supply of oxygen to tissue.
Hyperviscosity of the blood with increased circulatory resistance.
Hemoglobin < 8.5 g/dl > 23 g/dl Risk of multiorgan failure, especially if the patient has a combination of ischemia and hypoxia.
Abnormal flow kinetics (hyperviscosity) with increased circulatory resistance and an increased load on the heart. Igm > 20 mg/dl A cord blood IgM concentration above the limit can be linked to an intrauterine infection.
Potassium < 2.6 mmol/l ³ 7.7 mmol/l
Occurrence of neuromuscular symptoms with hyporeflexia and paralysis of the respiratory muscles.
Clinical consequences are heart-rhythm disturbances, weakness of the skeletal muscles, and respiratory paralysis.
Leukocyte count < 5,000/ml > 25,000/ml Values below and above these limits can be indicative of neonatal sepsis. pO2 < 37 mm Hg (4.9 Drop in hemoglobin oxygen saturation to below 85%. Table 3 : Neonatal quantitative limits of laboratory results which, after confirmation through repeat measurement in the same sample, need urgent notification by the physician.
